| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 66 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 66 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 66 |
| 3 | RITUXIMAB | 50 |
| 4 | FLUDARABINE PHOSPHATE | 49 |
| 5 | AXICABTAGENE CILOLEUCEL | 46 |
| 6 | BLINATUMOMAB | 32 |
| 7 | PREDNISONE | 27 |
| 8 | DOXORUBICIN | 25 |
| 9 | DEXAMETHASONE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 46 | 0.0045 |
| 1 | BREXUCABTAGENE AUTOLEUCEL | 8 | 0.0037 |
| 2 | BLINATUMOMAB | 32 | 0.0030 |
| 3 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 4 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | ISRADIPINE | 1 | 0.0018 |
| 6 | IDECABTAGENE VICLEUCEL | 2 | 0.0016 |
| 7 | SILTUXIMAB | 1 | 0.0015 |
| 8 | I. V. FAT EMULSION | 1 | 0.0014 |
| 9 | INOTUZUMAB OZOGAMICIN | 4 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 46 | 0.0045 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | CD22-directed Immunoconjugate [EPC] | 4 | 0.0013 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 5 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 6 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 5 | 0.0003 |